The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: US tech titans, AstraZeneca in focus

Wed, 29th Jul 2020 16:19

(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.




But the US economy won't be far from investors minds either, as the Commerce Department releases second quarter US gross domestic product data that economists at Barclays Research anticipate will show an annualised 35% drop in activity.

Some analysts believe that their updates may well set the tone for over the entire month of August.

In the UK on the other hand, the only noteworthy release will be for motor vehicle production in June.

Across the Channel meanwhile, readings are due out for monthly unemployment in Germany and Italy, alongside second quarter GDP readings in Austria, Belgium and Germany.



The earnings calendar for the UK is full on Thursday

In the case of AstraZeneca, UBS analyst Michael Leuchten sees first half revenues coming in at $6.33bn (consensus: $6.25bn) and core earnings per share at $0.93 (consensus: $0.92).

Focus would be on the drugmaker's work on a Covid-19 vaccine alongside Oxford University, which was currently considered the front-runner in the global race to find a vaccine.

But concerns around cash generation were likely to resurface as well.

"Top-line momentum remains key for investors, in particular Tagrisso (UBSe of $1,013m vs cons. $1,031m), Lynparza (UBSe of $460m vs cons. $412m) and Imfinzi (UBSe $478m vs cons $465m). Calquence uptake will be of interest (UBSe of $102m vs cons. $103m). We will also look for any commentary around COVID-19 potential impact in H2 and the path to recovery."

Thursday 29 July

FINALS

The Panoply Holdings

INTERIMS

SEGRO, Kcell Joint Stock Co GDR (Reg S), BAE Systems, Franchise Brands, Greencoat UK Wind, Hutchison China Meditech Ltd, Inchcape, Robert Walters, Rentokil Initial, Goco Group, Schroders, AstraZeneca

Q2

Schroders, AstraZeneca, Royal Dutch Shell 'A', Royal Dutch Shell 'B'

TRADING ANNOUNCEMENTS

Compass Group, Gem Diamonds Ltd. (DI), Evraz, Volution Group

AGMs

Norcros, Card Factory, OnTheMarket, BMO Global Smaller Companies, Highland Gold Mining Ltd., Volex, London & Associated Properties, TMT Investments, Angling Direct, Gabelli Value Plus Trust, Stobart Group Ltd.

FINAL EX-DIVIDEND DATE

Anexo Group, Ventus 2 VCT 'C' Shares, Monks Inv Trust, Ventus VCT, Ventus 2 VCT D Shs, Keller Group, Ventus 2 VCT, Ventus VCT D Shs

FINAL DIVIDEND PAYMENT DATE

Anglo Asian Mining

INTERIM EX-DIVIDEND DATE

Investment Company, Hansa Investment Company Limited (DI), Aberdeen Asian Income Fund Ltd., BB Healthcare Trust (Red), Hansa Investment Company Limited 'A' Non Vtg (DI), Independent Inv Trust, Secure Income Reit, RELX plc, Nichols, Blackstone/GSO Loan Financing Limited, Blackrock Throgmorton Trust, GCP Infrastructure Investments Ltd, Aew UK Reit, Value and Income Trust, Henderson International Income Trust, Maven Income and Growth VCT 5, Schroder Real Estate Investment Trust Ltd, Starwood European Real Estate Finance Ltd, GCP Asset Backed Income Fund Limited, Henderson Far East Income Ltd., Maven Income & Growth 3 VCT, Foresight Solar Fund Limited, Ecofin Global Utilities and Infrastructure Trust

INTERIM DIVIDEND PAYMENT DATE

Robinson

SPECIAL EX-DIVIDEND DATE

Keller Group

QUARTERLY EX-DIVIDEND DATE

Marble Point Loan Financing Limited NPV, SME Credit Realisation Fund Limited NPV, City of London Inv Trust

QUARTERLY PAYMENT DATE

Real Estate Credit Investments Ltd

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Unemployment Rate (GER) (08:55)

GDP (Preliminary) (GER) (09:00)

Business Climate Indicator (EU) (10:00)

Industrial Confidence (EU) (10:00)

Economic Sentiment Indicator (EU) (10:00)

Unemployment Rate (EU) (10:00)

Services Sentiment (EU) (10:00)

Services Confidence (EU) (10:00)

GDP (Preliminary) (US) (13:30)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)



More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.